Popular Trials
Behavioral Intervention
STEPPT for Back Pain
Recruiting1 award2 criteria
San Diego, California
This trial aims to test a new intervention called STEPPT to address differences in how Hispanic and Non-Hispanic White patients are referred to and follow through with physical therapy for spine pain. The study will
Behavioral Intervention
Self-Management Programs for Chronic Back and Neck Pain
Recruiting1 award1 criteria
Minneapolis, Minnesota
This trial aims to see how well two community-based self-management programs work for people with chronic back or neck pain from minoritized populations. The study will compare a program teaching mind-body skills like mindfulness and
Popular Filters
Trials for Low Back Pain Patients
Behavioural Intervention
Self-Management Strategies for Lower Back Pain
Recruiting1 award8 criteria
Gainesville, Florida
This trial compares two strategies to help horticulture workers manage pain & ergonomic risks without medication. They'll be surveyed & videoed pre- & post-intervention & interviewed to explain outcomes.
Behavioral Intervention
Psychosocial Treatments for Chronic Pain
Recruiting1 award11 criteria
Chicago, Illinois
This trial aims to improve the effectiveness of psychosocial treatments for chronic musculoskeletal pain by understanding the most effective treatment mechanisms and patient-treatment matches.
Cell Therapy
Alocyte for Back Pain
Recruiting1 awardPhase 1
North Miami, Florida
This trial is testing Alocyte, a treatment made from umbilical cord blood, on patients with back pain due to issues in their spine joints. Current treatments don't fix the underlying problem. Alocyte aims to reduce inflammation and help the body repair itself, potentially providing longer-lasting relief. Amniotic membrane and umbilical cord (AMUC) particulate may be useful in relieving pain and inhibiting the degenerative cascade in patients with discogenic pain by reducing inflammation.
Trials for Lower Back Pain Patients
Behavioural Intervention
Self-Management Strategies for Lower Back Pain
Recruiting1 award8 criteria
Gainesville, Florida
This trial compares two strategies to help horticulture workers manage pain & ergonomic risks without medication. They'll be surveyed & videoed pre- & post-intervention & interviewed to explain outcomes.
Behavioral Intervention
Psychosocial Treatments for Chronic Pain
Recruiting1 award11 criteria
Chicago, Illinois
This trial aims to improve the effectiveness of psychosocial treatments for chronic musculoskeletal pain by understanding the most effective treatment mechanisms and patient-treatment matches.
Cell Therapy
Alocyte for Back Pain
Recruiting1 awardPhase 1
North Miami, Florida
This trial is testing Alocyte, a treatment made from umbilical cord blood, on patients with back pain due to issues in their spine joints. Current treatments don't fix the underlying problem. Alocyte aims to reduce inflammation and help the body repair itself, potentially providing longer-lasting relief. Amniotic membrane and umbilical cord (AMUC) particulate may be useful in relieving pain and inhibiting the degenerative cascade in patients with discogenic pain by reducing inflammation.
Trials With No Placebo
Behavioural Intervention
Self-Management Strategies for Lower Back Pain
Recruiting1 award8 criteria
Gainesville, Florida
This trial compares two strategies to help horticulture workers manage pain & ergonomic risks without medication. They'll be surveyed & videoed pre- & post-intervention & interviewed to explain outcomes.
Behavioral Intervention
Psychosocial Treatments for Chronic Pain
Recruiting1 award11 criteria
Chicago, Illinois
This trial aims to improve the effectiveness of psychosocial treatments for chronic musculoskeletal pain by understanding the most effective treatment mechanisms and patient-treatment matches.
Cell Therapy
Alocyte for Back Pain
Recruiting1 awardPhase 1
North Miami, Florida
This trial is testing Alocyte, a treatment made from umbilical cord blood, on patients with back pain due to issues in their spine joints. Current treatments don't fix the underlying problem. Alocyte aims to reduce inflammation and help the body repair itself, potentially providing longer-lasting relief. Amniotic membrane and umbilical cord (AMUC) particulate may be useful in relieving pain and inhibiting the degenerative cascade in patients with discogenic pain by reducing inflammation.
Bone Graft Extender
MagnetOs Putty for Spinal Fusion
Recruiting1 award4 criteria
Detroit, Michigan
This trial is designed to assess the safety and effectiveness of MagnetOs Putty as a bone graft extender mixed with autograft in patients undergoing posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), or lumbar interbody fusion (LIF).
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.